https://www.selleckchem.com/products/cpi-203.html
Results were summarised with mean change and 95% CI. RESULTS DYT-TOR1A (68%, 38.4 points; p less then 0.001), DYT-THAP1 (37% 14.5 points; p less then 0.001) and NBIA/DYT-PANK2 (27%, 21.4 points; p less then 0.001) improved in BFMMS; only DYT-TOR1A improved in BFMDS (69%, 9.7 points; p less then 0.001). Improvement in DYT-TOR1A was significantly greater than in DYT-THAP1 (BFMMS -31%), NBIA/DYT-PANK2 (BFMMS -35%; BFMDS -53%) and CHOR/DYT-ADCY5 (BFMMS -36%; BFMDS -42%). Worse motor outcomes were associated with longer dystonia duration and
Like
Comment
Share
